Recall of Covidien Shiley Neonatal, Pediatric and Long Pediatric Tracheostomy Tube with TaperGuard Cuff

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Covidien LLC.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    18521
  • Event Initiated Date
    2015-05-19
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Covidien NZ Ltd, Level 3, Building 5, Central Park Corporate Centre, 666 Great South Road, Penrose, AUCKLAND 1051
  • Reason
    Covidien has recalled these devices following reports from customers, where patients who recently switched from the current shiley™ neonatal and pediatric products to the affected products, experienced discomfort immediately after the switch in a limited number of situations. in some cases, breathing difficulties, corresponding to a negative effect on oxygen levels, were also observed immediately after the switch.
  • Action
    Product to be returned to supplier

Device

  • Model / Serial
    Model: Product Numbers: 2.5NCF, 3.0NCF, 3.5NCF, 4.0NCF, 4.5NCF, 2.5PCF, 3.0PCF, 3.5PCF, 4.0PCF, 4.5PCF, 5.0PCF, 5.5PCF, 5.0PLCF, 5.5PLCF, 6.0PLCF, 6.5PLCF, Affected: All lot numbers beginning with 12, 13, and 14, plus 15A0151JZX to 15AO155JZX
  • Product Classification
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NZMMDSA